Home » Headlines » Currently Reading:

Morning Headlines 8/31/17

August 30, 2017 Headlines 2 Comments

AHA Letter To Representative Pat Tiberi

AHA writes a letter to Rep. Pat Tiberi (R-OH), Chairman of the Committee on Ways and Means’ Subcommittee on Health, calling for the cancellation of Meaningful Use Stage 3.

FDA approval brings first gene therapy to the United States

The FDA has approved CAR-T, a gene therapy treatment for certain types of pediatric leukemia, making it the first gene therapy approved for use in the US. Novartis developed the treatment and has put a $475,000 price tag on the drug, far below analyst expectations. In a clinical trial, a single dose of CAR-T left 83 percent of participants cancer free after three months.

Medtronic invests $40 million in robotics company Mazor

Medtronic announces that it has invested $40 million in surgical robot vendor Mazor Robotics, bringing its total investment in the company to $72 million. Medtronic will now become the exclusive distributor of Mazor’s robotic surgery system.

Aetna scoops up rising star from Wal-Mart’s health group to lead Apple Watch partnership

Aetna hires Walmart’s health division director Ben Wanamaker to lead its joint venture with Apple.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "2 comments" on this Article:

  1. Folks should remember that killing MU3 would hurt Medicaid providers much more than hospitals or Medicare EPs. The Medicaid program has a few more years of funding left in it. The other programs – for most hospitals and EPs – do not, and have shifted into the penalty phase.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • EHR Guy: I enjoyed your comments about Epic and their CEO Judy. In watching and being in the industry over the years as Epic has ...
  • EHR Guy: how so... Pretty straight forward. Please explain if you are going to comment....
  • EHR Gal: This was incoherent. Please edit and try again....
  • EHR Guy: I enjoyed your comments about Epic and their CEO Judy. In watching and being in the industry over the years as Epic has...
  • KP Alum: Re the Kaiser Permanente medical school: I think it makes a lot of sense for them to train physicians in how Permanente ...
  • EHRVendor: Good article, unfortunately, this lost credibility when Athenahealth was considered one of the five major EHR Vendors le...
  • Patient advocate: Hi. I don’t see our organization on the Commonwell slide. We have gotten a lot of value from the tool and have ac...
  • Anonymous: I worked for Cerner at the time of the fire, and Cerner had a few dozen associates at the Feather River facilities. Both...
  • monica: 'Champions of Heath' that is perfect and says more about the whole rebranding strategy in 3 words than I could in a para...
  • Bill Spooner: It would be great to know about healthcare costs and outcomes in China, India and Norway, to learn how the various care ...

Sponsor Quick Links